SPX 0.36% VIX -3.15%
RED ROBIN STOCK JUMPS 13% AFTER TAKEOVER BID 
BOEING TO TAKE $4.9 BLN CHARGE IN SECOND QUARTER ON 737 MAX GROUNDING 
CROWDSTRIKE STOCK RALLIES 8% AFTER BETTER-THAN-EXPECTED OUTLOOK 
MICROSOFT STOCK RISES AS EARNINGS TOP EXPECTATIONS 
U.S. STOCKS END WITH MODEST GAINS AFTER FED'S WILLIAMS SPURS RATE-CUT HOPES 
STOCKS HAVE JUMPED TO THEIR HIGHS OF THE DAY AS INTEREST-RATE-CUT HOPES RISE 
SILVER, AFTER LAGGING GOLD, HAS RALLIED TO ITS HIGHEST LEVEL IN MORE THAN A YEAR 
DOW INDUSTRIALS DOWN 130 POINTS AS THURSDAY STOCK-MARKET DECLINES STEEPEN 
FOR THE DOW EARLY THURSDAY, IBM AND UNITEDHEALTH ARE EQUAL, OPPOSING FORCES 
U.S. STOCKS ON TRACK THURSDAY MORNING FOR THIRD STRAIGHT DOWN DAY 
Thu, Jul 18 11:43pm


Celgene Corp [CELG]
$90.91 0.04 (0.04%)

CELG Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 64.12 Billion
CELG Description

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.


Visit Website

CELG Earnings

EPS 2.20 P/E Ratio 17.70
Previous Earnings Thu, Jan 31, 2019
Latest Earnings Thu, Apr 25, 2019 (84 days ago) -2.35%

CELG Dividend

Yield --
Ex-Date --
Pay Date --
History --

CELG Charts

$59.14
52 Week Range
$98.97
Dec 24, 2018
Jun 21, 2019



Symbol Price Day % YTD %
CELG $90.91 0.04% 36.42%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy